MARKET

CDXC

CDXC

Chromadex Corp
NASDAQ
3.480
-0.190
-5.18%
After Hours: 3.490 +0.01 +0.29% 19:30 03/28 EDT
OPEN
3.610
PREV CLOSE
3.670
HIGH
3.770
LOW
3.170
VOLUME
489.66K
TURNOVER
0
52 WEEK HIGH
4.060
52 WEEK LOW
1.250
MARKET CAP
262.08M
P/E (TTM)
-52.8073
1D
5D
1M
3M
1Y
5Y
ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
ChromaDex Corp. Announces its flagship Tru Niagen product portfolio is now third-party verified through the Alkemist Assured™ testing transparency program. AlkeMist Labs is a leading testing laboratory known for its rigorous herbal and dietary supplement analysis. The company is the number one healthy-aging NAD+ supplement company in the United States. TruNiagen features the most efficient, patented, superior quality NAD+ precursor on the market.
Barchart · 2d ago
Weekly Report: what happened at CDXC last week (0318-0322)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Fresh2 Group (NASDAQ:FRES) shares rose 41.7% to $0.66 during Monday's regular session. Akso Health Group stock moved upwards by 29.0%. ChromaDex stock rose upwards by 27.91%. Trxade Health shares declined by 33.0% during the session.
Benzinga · 03/18 17:31
Weekly Report: what happened at CDXC last week (0311-0315)?
Weekly Report · 03/18 12:04
Weekly Report: what happened at CDXC last week (0304-0308)?
Weekly Report · 03/11 11:59
ChromaDex Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 03/11 11:33
ChromaDex Price Target Raised to $6.00/Share From $5.00 by HC Wainwright & Co.
Dow Jones · 03/11 11:33
HC Wainwright & Co. Maintains Buy on ChromaDex, Raises Price Target to $6
Benzinga · 03/11 11:23
More
About CDXC
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Webull offers Chromadex Corp stock information, including NASDAQ: CDXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXC stock methods without spending real money on the virtual paper trading platform.